Drugs / standardized cannabis extract
standardized cannabis extract
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00552604 | Jun 2006 → Nov 2008 | — | Institut fur Klinische Forschung, Germany | Terminated | Met primary Stop: Enrollment |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | standardized cannabis extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00552604 ↗ |
| Known as | Cannabis extract | “Cannabis extract (delta-9-THC 2.5mg, CBD 1.25 mg per capsule), flexible dosing between 5 mg and 25 mg THC/d, administered twice daily” NCT00552604 ↗ |
| Known as | oral cannabis extract | “Patients with stable MS at 22 UK centres were randomised to oral cannabis extract (CE) (N=144) or placebo (N=135)” PMID 22791906 ↗ Jul 2012 |
| Known as | standardised extract of Cannabis sativa | “a standardised extract of Cannabis sativa given orally 2 times daily as compared to placebo” NCT00552604 ↗ |
| Route | Oral | “a standardised extract of Cannabis sativa given orally 2 times daily” NCT00552604 ↗ |